These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30262415)

  • 21. Perioperative therapy for locoregional nonsmall-cell lung cancer.
    Takita H
    J Surg Oncol; 1996 May; 62(1):65-74. PubMed ID: 8618405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage III Non-small Cell Lung Cancer.
    Rusch VW
    Semin Respir Crit Care Med; 2016 Oct; 37(5):727-735. PubMed ID: 27732994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Latest therapeutic strategy for stage IV non-small cell lung cancer].
    Kawate N
    Nihon Rinsho; 2002 May; 60 Suppl 5():490-3. PubMed ID: 12101720
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update.
    Abdel-Rahman O; Morris D
    Immunotherapy; 2019 Feb; 11(3):149-153. PubMed ID: 30730273
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy tripleheader extends life for non-small cell lung cancer patients. Concurrent radiation, chemotherapy and lobectomy increase survival for those with NSCLC.
    Health News; 2005 Oct; 11(10):5-6. PubMed ID: 16250091
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination immunotherapy for advanced lung cancer.
    Yang SC; Grimm EA; Roth JA
    J Natl Cancer Inst Monogr; 1992; (13):197-201. PubMed ID: 1327033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti PD-L1 combined with other agents in non-small cell lung cancer: combinations with non-immuno-oncology agents.
    Puri S; Chatwal M; Gray JE
    Expert Rev Respir Med; 2017 Oct; 11(10):791-805. PubMed ID: 28786318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced non-small-cell lung cancer: to treat or not to treat?
    Hansen HH
    J Clin Oncol; 1987 Nov; 5(11):1711-2. PubMed ID: 2824704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC.
    Benitez JC; Mezquita L; Colle R; Tselikas L; Botticella A; Caramella C; Besse B
    J Thorac Oncol; 2019 Oct; 14(10):e215-e216. PubMed ID: 31302233
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine immunotherapy in lung cancer: Clinical experience and future directions.
    Freeman-Keller M; Goldman J; Gray J
    Pharmacol Ther; 2015 Sep; 153():1-9. PubMed ID: 25989231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.
    Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS
    Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of combination chemo-immunotherapy in advanced non-small cell lung cancer.
    Rocco D; Della Gravara L; Battiloro C; Gridelli C
    Expert Rev Anticancer Ther; 2019 Jul; 19(7):561-568. PubMed ID: 31188040
    [No Abstract]   [Full Text] [Related]  

  • 36. Multimodality treatment in locally advanced non-small cell lung cancer.
    Trodella L; D'Angelillo RM; Ramella S; Granone P
    Ann Oncol; 2006 Mar; 17 Suppl 2():ii32-33. PubMed ID: 16608977
    [No Abstract]   [Full Text] [Related]  

  • 37. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
    Bonomi P; Reddy S; Faber LP
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer.
    Reck M
    Immunotherapy; 2018 Feb; 10(2):93-105. PubMed ID: 29145737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer.
    Hansen HH; Rørth M
    Cancer Chemother Biol Response Modif; 1991; 12():443-59. PubMed ID: 1657089
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical application of adoptive immunotherapy in patients with progressive lung cancer].
    Cho T; Yoshizawa H
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1543-8. PubMed ID: 7798747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.